Akb-6548-Ci-0015
Research payments
$5,615,573
Through program year 2022, $5,615,573 in research payments was reported against Akb-6548-Ci-0015, across 6,381 payments, paid by Akebia Therapeutics Inc.
- Paid by
- Akebia Therapeutics Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $199,960 | 248 |
| 2019 | Research | $5,415,613 | 6,133 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Pusadee Suchinda Sumter, SC Named on 286 payments
- Ram Patak Northridge, CA Named on 202 payments
- Asha Bailey Columbia, SC Named on 185 payments
- Fernando Trespalacios Miami, FL Named on 183 payments
- Sohan Dua Northridge, CA Named on 178 payments
- Nauman Shahid Greenville, NC Named on 152 payments
- Manuel Montero New Bern, NC Named on 147 payments
- Andrew O'Shaughnessy Fort Wayne, IN Named on 145 payments
- Claude Galphin Chattanooga, TN Named on 122 payments
- Ahmed Awad Kansas City, MO Named on 118 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.